Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients

Background: Widespread neural and microvascular injuries are common in chronic kidney disease (CKD), increasing risks of neurovascular complications and mortality. Early detection of such changes helps assess the risks of neurovascular complications for CKD patients. As an extension of central nervo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaomin Zeng, Yijun Hu, Yuanhan Chen, Zhanjie Lin, Yingying Liang, Baoyi Liu, Pingting Zhong, Yu Xiao, Cong Li, Guanrong Wu, Huiqian Kong, Zijing Du, Yun Ren, Ying Fang, Zhiming Ye, Xiaohong Yang, Honghua Yu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/1dd9c39fa407474a82dd245b1954614d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1dd9c39fa407474a82dd245b1954614d
record_format dspace
spelling oai:doaj.org-article:1dd9c39fa407474a82dd245b1954614d2021-11-18T09:43:33ZRetinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients1662-453X10.3389/fnins.2021.703898https://doaj.org/article/1dd9c39fa407474a82dd245b1954614d2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnins.2021.703898/fullhttps://doaj.org/toc/1662-453XBackground: Widespread neural and microvascular injuries are common in chronic kidney disease (CKD), increasing risks of neurovascular complications and mortality. Early detection of such changes helps assess the risks of neurovascular complications for CKD patients. As an extension of central nervous system, the retina provides a characteristic window to observe neurovascular alterations in CKD. This study aimed to determine the presence of retinal neurovascular impairment in different stages of CKD.Methods: One hundred fifteen non-diabetic and non-dialytic CKD patients of all stages and a control group of 35 healthy subjects were included. Retinal neural and microvascular parameters were obtained by optical coherence tomography angiography (OCTA) examination.Results: CKD 1–2 group (versus control group) had greater odds of having decreased retinal ganglion cell-inner plexiform layer thickness (GC-IPLt) (odds ratio [OR]: 0.92; 95% confidence interval [CI]: 0.86–0.98), increased ganglion cell complex-focal loss volume (GCC-FLV) (OR: 3.51; 95% CI: 1.27–9.67), and GCC-global loss volume (GCC-GLV) (OR: 2.48; 95% CI: 1.27–4.82). The presence of advanced stages of CKD (CKD 3–5 group versus CKD 1–2 group) had greater odds of having decreased retinal vessel density in superficial vascular plexus (SVP)-WholeImage (OR: 0.77, 95% CI: 0.63–0.92), SVP-ParaFovea (OR: 0.83, 95% CI: 0.71–0.97), SVP-ParaFovea (OR: 0.76, 95% CI: 0.63–0.91), deep vascular plexus (DVP)-WholeImage (OR: 0.89, 95% CI: 0.81–0.98), DVP-ParaFovea (OR: 0.88, 95% CI: 0.78–0.99), and DVP-PeriFovea (OR: 0.90, 95% CI: 0.83–0.98). Besides, stepwise multivariate linear regression among CKD patients showed that β2-microglobulin was negatively associated with GC-IPLt (β: –0.294; 95% CI: –0.469 ∼ –0.118), and parathyroid hormone was positively associated with increased GCC-FLV (β: 0.004; 95% CI: 0.002∼0.006) and GCC-GLV (β: 0.007; 95% CI: 0.004∼0.01). Urine protein to creatinine ratio was positively associated with increased GCC-FLV (β: 0.003; 95% CI: 0.001∼0.004) and GCC-GLV (β: 0.003; 95% CI: 0.001∼0.006).Conclusion: Retinal neuronal impairment is present in early stages of CKD (stages 1–2), and it is associated with accumulation of uremic toxins and higher UACR, while retinal microvascular hypoperfusion, which is associated with worse eGFR, was only observed in relatively advanced stages of CKD (stages 3–5). The results highlight the importance of monitoring retinal neurovascular impairment in different stages of CKD.Xiaomin ZengXiaomin ZengYijun HuYijun HuYuanhan ChenZhanjie LinZhanjie LinYingying LiangYingying LiangBaoyi LiuBaoyi LiuPingting ZhongPingting ZhongYu XiaoYu XiaoCong LiCong LiGuanrong WuGuanrong WuHuiqian KongHuiqian KongZijing DuZijing DuYun RenYun RenYing FangZhiming YeXiaohong YangXiaohong YangHonghua YuHonghua YuFrontiers Media S.A.articleretinal imagingneuronal impairmentmicrovascular hypoperfusionoptical coherence tomography angiography (OCTA)chronic kidney diseaseNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Neuroscience, Vol 15 (2021)
institution DOAJ
collection DOAJ
language EN
topic retinal imaging
neuronal impairment
microvascular hypoperfusion
optical coherence tomography angiography (OCTA)
chronic kidney disease
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle retinal imaging
neuronal impairment
microvascular hypoperfusion
optical coherence tomography angiography (OCTA)
chronic kidney disease
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Xiaomin Zeng
Xiaomin Zeng
Yijun Hu
Yijun Hu
Yuanhan Chen
Zhanjie Lin
Zhanjie Lin
Yingying Liang
Yingying Liang
Baoyi Liu
Baoyi Liu
Pingting Zhong
Pingting Zhong
Yu Xiao
Yu Xiao
Cong Li
Cong Li
Guanrong Wu
Guanrong Wu
Huiqian Kong
Huiqian Kong
Zijing Du
Zijing Du
Yun Ren
Yun Ren
Ying Fang
Zhiming Ye
Xiaohong Yang
Xiaohong Yang
Honghua Yu
Honghua Yu
Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
description Background: Widespread neural and microvascular injuries are common in chronic kidney disease (CKD), increasing risks of neurovascular complications and mortality. Early detection of such changes helps assess the risks of neurovascular complications for CKD patients. As an extension of central nervous system, the retina provides a characteristic window to observe neurovascular alterations in CKD. This study aimed to determine the presence of retinal neurovascular impairment in different stages of CKD.Methods: One hundred fifteen non-diabetic and non-dialytic CKD patients of all stages and a control group of 35 healthy subjects were included. Retinal neural and microvascular parameters were obtained by optical coherence tomography angiography (OCTA) examination.Results: CKD 1–2 group (versus control group) had greater odds of having decreased retinal ganglion cell-inner plexiform layer thickness (GC-IPLt) (odds ratio [OR]: 0.92; 95% confidence interval [CI]: 0.86–0.98), increased ganglion cell complex-focal loss volume (GCC-FLV) (OR: 3.51; 95% CI: 1.27–9.67), and GCC-global loss volume (GCC-GLV) (OR: 2.48; 95% CI: 1.27–4.82). The presence of advanced stages of CKD (CKD 3–5 group versus CKD 1–2 group) had greater odds of having decreased retinal vessel density in superficial vascular plexus (SVP)-WholeImage (OR: 0.77, 95% CI: 0.63–0.92), SVP-ParaFovea (OR: 0.83, 95% CI: 0.71–0.97), SVP-ParaFovea (OR: 0.76, 95% CI: 0.63–0.91), deep vascular plexus (DVP)-WholeImage (OR: 0.89, 95% CI: 0.81–0.98), DVP-ParaFovea (OR: 0.88, 95% CI: 0.78–0.99), and DVP-PeriFovea (OR: 0.90, 95% CI: 0.83–0.98). Besides, stepwise multivariate linear regression among CKD patients showed that β2-microglobulin was negatively associated with GC-IPLt (β: –0.294; 95% CI: –0.469 ∼ –0.118), and parathyroid hormone was positively associated with increased GCC-FLV (β: 0.004; 95% CI: 0.002∼0.006) and GCC-GLV (β: 0.007; 95% CI: 0.004∼0.01). Urine protein to creatinine ratio was positively associated with increased GCC-FLV (β: 0.003; 95% CI: 0.001∼0.004) and GCC-GLV (β: 0.003; 95% CI: 0.001∼0.006).Conclusion: Retinal neuronal impairment is present in early stages of CKD (stages 1–2), and it is associated with accumulation of uremic toxins and higher UACR, while retinal microvascular hypoperfusion, which is associated with worse eGFR, was only observed in relatively advanced stages of CKD (stages 3–5). The results highlight the importance of monitoring retinal neurovascular impairment in different stages of CKD.
format article
author Xiaomin Zeng
Xiaomin Zeng
Yijun Hu
Yijun Hu
Yuanhan Chen
Zhanjie Lin
Zhanjie Lin
Yingying Liang
Yingying Liang
Baoyi Liu
Baoyi Liu
Pingting Zhong
Pingting Zhong
Yu Xiao
Yu Xiao
Cong Li
Cong Li
Guanrong Wu
Guanrong Wu
Huiqian Kong
Huiqian Kong
Zijing Du
Zijing Du
Yun Ren
Yun Ren
Ying Fang
Zhiming Ye
Xiaohong Yang
Xiaohong Yang
Honghua Yu
Honghua Yu
author_facet Xiaomin Zeng
Xiaomin Zeng
Yijun Hu
Yijun Hu
Yuanhan Chen
Zhanjie Lin
Zhanjie Lin
Yingying Liang
Yingying Liang
Baoyi Liu
Baoyi Liu
Pingting Zhong
Pingting Zhong
Yu Xiao
Yu Xiao
Cong Li
Cong Li
Guanrong Wu
Guanrong Wu
Huiqian Kong
Huiqian Kong
Zijing Du
Zijing Du
Yun Ren
Yun Ren
Ying Fang
Zhiming Ye
Xiaohong Yang
Xiaohong Yang
Honghua Yu
Honghua Yu
author_sort Xiaomin Zeng
title Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
title_short Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
title_full Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
title_fullStr Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
title_full_unstemmed Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
title_sort retinal neurovascular impairment in non-diabetic and non-dialytic chronic kidney disease patients
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/1dd9c39fa407474a82dd245b1954614d
work_keys_str_mv AT xiaominzeng retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT xiaominzeng retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yijunhu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yijunhu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yuanhanchen retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT zhanjielin retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT zhanjielin retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yingyingliang retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yingyingliang retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT baoyiliu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT baoyiliu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT pingtingzhong retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT pingtingzhong retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yuxiao retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yuxiao retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT congli retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT congli retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT guanrongwu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT guanrongwu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT huiqiankong retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT huiqiankong retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT zijingdu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT zijingdu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yunren retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yunren retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT yingfang retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT zhimingye retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT xiaohongyang retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT xiaohongyang retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT honghuayu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
AT honghuayu retinalneurovascularimpairmentinnondiabeticandnondialyticchronickidneydiseasepatients
_version_ 1718420889439043584